ISN 9.09% 6.0¢ isonea limited

the world order of asthma apps has began, page-20

  1. 7,746 Posts.
    "You see, the video doesnt give a feel it, touch it use it effect"

    Are you saying management have failed to capture the essence of the app in their marketing video? If so this would surely be detrimental to sales.

    Also would it not be a concern that the existing Wheezeometer is incompatible with the new app? Certainly explains why sales have stalled given that it is obsolete. You really have no choice but to wait and buy the 'new device' or you're throwing $400 away.

    I agree it probably is wise to download the app as an investor or prospective investor to see where $4mil has gone and determine if you have belief or not.

    But I think some holders will go too far and write reviews. I'm speaking with experience from PNO (sorry to cross promote). Their product is Thermalife arthritis cream. Most sales seem to be from HC posters. And many reviews have appeared on HC and then become testimonials for the product.

    Not surprisingly they read like shareholder reviews and are more detrimental than constructive.
 
watchlist Created with Sketch. Add ISN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.